Polyplus Raises $3.3M in Private Financing | GenomeWeb

Polyplus Transfection said this week that it has raised €2.5 million ($3.3 million) through a round of private financing.

The round brings in new investors Alsace Inter Regio Fonds d’Investissement and Sudinnova, while existing investors CIC Vizille Capital Innovation and CIC Finance also participated.

The company said it will use the funds to advance new siRNA delivery compounds and add 10 new researchers and lab technicians, which would bring its total headcount to 40.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.